Atlas Trials

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

Clinical trial NCT04442581 · TERMINATED

Trial details

NCT number
NCT04442581
Sponsor
University of Washington
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Start date
2021-04-20
Primary completion
2021-12-13
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.